*JB Chemicals & Pharmaceuticals* manufacturers of a wide range of innovative specialty medicines for the domestic and international markets, today disclosed a substantial rise in standalone net profit for the quarter ended December 2008. During the quarter, the profit of the company rose 33.45% to Rs 142.40 million from Rs 106.71 million in the same quarter previous year.
Net sales for the quarter jumped 60.45% to Rs 2,230.54 million, while total income for the quarter jumped 51.94% to Rs 2,234.86 million, when compared with the prior year period. The company posted earnings of Rs 1.69 a share during the quarter, registering 33.07% growth over prior year period. *Quarterly Results - Standalone (Rs in mn)* *As at* *Dec - 08* *Dec - 07* *%Change* *Net Sales* 2,230.54 1,390.17 60.45 *Net Profit* 142.40 106.71 33.45 *Basic EPS* 1.69 1.27 33.07 During the quarter, the operating margin of the company increased by 758.05 basis points to 15.76% compared with the previous year period. Interest cost decreased 7.30% to Rs 35.55 million while depreciation cost rose 23.64% to Rs 51.25 million over previous year period. --~--~---------~--~----~------------~-------~--~----~ You received this message because you are subscribed to the Google Groups "Kences1" group. To post to this group, send email to [email protected] To unsubscribe from this group, send email to [email protected] For more options, visit this group at http://groups.google.com/group/kences1?hl=en -~----------~----~----~----~------~----~------~--~---
